美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

GSK plc ADRhedged

67.19

+0.89981.36%

成交量：3

成交额：199

市值：67.19万

市盈率：- -

高：67.19

开：66.29

低：67.19

收：66.29

52周最高：85.03

52周最低：61.00

股本：1.00万

流通股本：1.00万

量比：0.01

换手率：0.03%

股息：2.07

股息率：3.09%

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

司美格鲁肽专利悬崖在前诺和诺德如何只靠新产品完成1500亿丹麦克朗销售目标？

每日经济新闻

科创板集成电路、创新药研发成果进入实质兑现期

中国经营报

据报道，Summit Therapeutics（SMMT）周一表示，英国制药公司阿斯利康（AstraZeneca，AZN

公告精选︱科达制造：拟投资约45亿元建设年产50万吨石墨负极材料一体化项目；百花医药：不涉及创新药研发

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/GSKH"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GSKH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","market":"US","secType":"STK","nameCN":"GSK plc ADRhedged","latestPrice":67.1856,"timestamp":1791835200000,"preClose":66.2858,"halted":0,"volume":3,"delay":0,"changeRate":0.013574551412217988,"floatShares":10001,"shares":10001,"eps":0,"marketStatus":"未开盘","change":0.8998,"latestTime":"10-12 16:00:00 EDT","open":66.2858,"high":67.1856,"low":67.1856,"amount":199,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1791878400000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":66.2858,"nav":66.281474,"aum":662881.021474,"dividendRate":0.030899,"bidAskSpread":0,"volumeRatio":0.010482,"impliedVol":0.3657,"impliedVolPercentile":0.9925},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","floatShares":10001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.010482,"shares":10001,"dividePrice":2.0748,"high":67.1856,"amplitude":0,"preClose":66.2858,"low":67.1856,"week52Low":61,"pbRate":"--","week52High":85.03,"institutionHeld":0,"latestPrice":67.1856,"eps":0,"divideRate":0.030882,"volume":3,"delay":0,"ttmEps":0,"open":66.2858,"prevYearClose":68.2031,"prevWeekClose":66.2858,"prevMonthClose":68.5811,"prevQuarterClose":68.5811,"fiveDayClose":66.3846,"twentyDayClose":69.8025,"sixtyDayClose":71.9041},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSKH\",params:#limit:5,,,undefined,":[{"date":"2026-06-16","symbol":"GSKH","amount":0.92785,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"GSKH","amount":0.36332,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"GSKH","amount":0.78682,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSKH\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.78682,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.36332,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.92785,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GSKH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSKH\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673602556","title":"司美格鲁肽专利悬崖在前 诺和诺德如何只靠新产品完成1500亿丹麦克朗销售目标？","url":"https://stock-news.laohu8.com/highlight/detail?id=2673602556","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673602556?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 14:07","pubTimestamp":1791439654,"startTime":"0","endTime":"0","summary":"近日，诺和诺德召开全球媒体沟通会。诺和诺德公司全球总裁兼CEO杜麦克（MikeDoustdar）、首席科学官MartinHolstLange、产品与产品组合战略全球执行副总裁周虹及国际运营部执行副总裁林意明（EmilKongshjLarsen）等集体出席，围绕核心分子司美格鲁肽的战略定位、口服制剂的全球部署以及管线与并购的推进逻辑，作出系统阐述。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610083889529730.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610083889529730.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IYH","TRUH","BBH","BGIA","MEDI","RSPH","FXH","BME","GSKH","PBPH","JDOC","BBP","PJP","IHE","PPH","FHLC","APXH","TMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673501811","title":"科创板集成电路、创新药研发成果进入实质兑现期","url":"https://stock-news.laohu8.com/highlight/detail?id=2673501811","media":"中国经营报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673501811?lang=zh_cn&edition=fundamental","pubTime":"2026-10-07 19:56","pubTimestamp":1791374163,"startTime":"0","endTime":"0","summary":"近期，科创板公司研发频传利好消息，从创新药的首例入组和新适应证获批，到集成电路的存储平台量产与核心芯片交付，越来越多成果转化为实实在在的创新产出，科创板硬科技企业正从“持续投入”走向“成果兑现”。集成电路板块多点突破，存储、端侧AI、模拟与车规芯片均有实质进展落地。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610073888922323.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610073888922323.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BBP","PBE","KSTR","WRND","BIOY","LFSC","XLVI","BK4585","BK4588","IBB","GDOC","APXH","159546","GSKH","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671265237","title":"据报道，Summit Therapeutics（SMMT）周一表示，英国制药公司阿斯利康（AstraZeneca，AZN","url":"https://stock-news.laohu8.com/highlight/detail?id=2671265237","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671265237?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 07:52","pubTimestamp":1790639529,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4539","BK4007","LENZ","GSKH","BK4139","LU2488822045.USD","SMMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669169682","title":"公告精选︱科达制造：拟投资约45亿元建设年产50万吨石墨负极材料一体化项目；百花医药：不涉及创新药研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2669169682","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669169682?lang=zh_cn&edition=fundamental","pubTime":"2026-09-21 21:52","pubTimestamp":1789998737,"startTime":"0","endTime":"0","summary":"逸豪新材：拟定增募资不超过18亿元用于增资收购铭丰电子不低于78%股权","market":"us","thumbnail":"https://img7.gelonghui.com/column/2/111.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/111.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/6758003","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK0102","BIOY","BK4585","BK0070","PBE","GSKH","IBB","BK0251","WRND","BK0155","GDOC","BBP","600499","BK0188","BK4588","600721","BK0216","XLVI","SETM","LFSC","APXH","SBIO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":23,"pageCount":1,"totalSize":91,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/GSKH\",params:#limit:6,delay:false,,,undefined,":[]}}